- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03786679
Non-operative Treatment in Sweden of Proximal Humeral Fractures (NOSWEPH)
February 17, 2021 updated by: Lars Adolfsson
Non-operative Treatment in Sweden of Proximal Humeral Fratures, a Randomised Multicenter Trial.
Proximal humeral fractures are common especially in the elderly population.
The majority of these fractures are minimally displaced and may be treated non-operatively.
There is however a controversy about which fractures that need surgery and randomised trials have not been able to show a clinically important advantage in patient reported outcome measures for those operated.
The trend is therefore that also displaced and comminute fractures are treated non-operatively.
There is however very little scientific support for how the non-operative treatment should be designed and performed.
Therefore this prospective multicenter study is aiming at investigating the benefit of a four week immobilisation orthosis as compared to early range of motion exercises for those patients not assigned for surgery one week after the trauma.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hanna C Björnsson Hallgren, MD, PhD
- Phone Number: 0046709473276
- Email: hanna.bjornsson.hallgren@regionostergotland.se
Study Locations
-
-
-
Linköping, Sweden, 58185
- Recruiting
- Lars Adolfsson
-
Contact:
- Hanna C Björnsson Hallgren, MD, PhD
- Phone Number: +46101031000
- Email: hanna.bjornsson.hallgren@regionostergotland.se
-
Contact:
- lars e adolfsson, MD, PhD
- Phone Number: +46101031000
- Email: lars.adolfsonb@regionostergotland.se
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- A proximal humeral fracture verified on radiology no older than 7-10 days.
Exclusion Criteria:
- Surgically treated proximal humeral fracture
- Fracture only involving the greater tuberosity
- Previous surgery in the fractured shoulder
- Ongoing malignancy in the fractured shoulder
- Neurologic disease
- Radiating pain from the neck in the affected arm
- Associated vascular or nerve injuries
- Dementia
- Alcohol abuse
- Unwilling to participate in the trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Orthosis group
An orthosis with the broken arm in neutral position fixed for four weeks.
After these four weeks the patient is instructed to start rehabilitation.
|
Application of orthosis and start of rehabilitation after four weeks.
|
Active Comparator: Early rehabilitation group
The patient is instructed to start early rehabilitation about one week after the trauma.
|
Application of orthosis and start of rehabilitation after four weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Union of fracture
Time Frame: Followed 12 months
|
recording of fracture union on radiological images
|
Followed 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxford shoulder score
Time Frame: 12 months
|
Shoulder specific patient reported outcome measure, PROM, with a maximum score of 48 points
|
12 months
|
Numerical pain reporting scale
Time Frame: 12 months
|
Patient reported outcome measure of pain at rest, at night and during activity in scales with 10 steps grading subjective assessment of pain
|
12 months
|
Quick DASH
Time Frame: 12 months
|
Patient reported outcome measure of shoulder function in a 11-item PROM
|
12 months
|
Global assessment of improvement
Time Frame: 12 months
|
Patient rated assessment of global improvement in a numeric scale with 7 steps
|
12 months
|
Shoulder range of motion
Time Frame: 12 months
|
The elevation, abduction, internal and external rotation of the injured shoulder
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lars E Adolfsson, Professor, Linkoeping University
- Principal Investigator: Hanna C Björnsson Hallgren, MD, PhD, Linkoeping University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 25, 2019
Primary Completion (Anticipated)
February 25, 2022
Study Completion (Anticipated)
February 25, 2024
Study Registration Dates
First Submitted
November 5, 2018
First Submitted That Met QC Criteria
December 23, 2018
First Posted (Actual)
December 26, 2018
Study Record Updates
Last Update Posted (Actual)
February 21, 2021
Last Update Submitted That Met QC Criteria
February 17, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 06000836
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Proximal Humeral Fracture
-
Massachusetts General HospitalCompletedProximal Humeral FracturesUnited States
-
Peking University People's HospitalUnknown
-
RWTH Aachen UniversityCompletedProximal Humeral FracturesGermany
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...CompletedHumeral Fracture, Proximal
-
Karolinska InstitutetCompleted
-
Herlev HospitalOdense University Hospital; Zealand University Hospital; Aalborg University HospitalUnknownProximal Humeral FracturesDenmark
-
University of Turin, ItalyRecruitingProximal Humeral FracturesItaly
-
Hospital del MarNot yet recruitingProximal Humeral Fractures, Reverse Shoulder Prostheses, Tuberosities
-
Oslo University HospitalDiakonhjemmet Hospital; Sykehuset Telemark; Helse Forde; Sykehuset Ostfold; Sykehuset... and other collaboratorsCompletedProximal Humeral Fractures, AO/OTA (2007) Group B2 and C2Norway
-
Xiaoxiao ZhouCompletedHumeral Fracture, Proximal | Internal Fixation; Complications, Mechanical, Bones of Limb
Clinical Trials on Ultrasling ER III orthosis
-
Queen Margaret UniversityNHS Lothian; Multiple Sclerosis Society UKCompletedMultiple Sclerosis | Foot DropUnited Kingdom
-
Boehringer IngelheimCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPoorly Differentiated Thyroid Gland Carcinoma | Thyroid Gland Squamous Cell Carcinoma | Unresectable Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 | Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8United States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States